Table 4 Association between the human GEO deposits’ technology used (high-throughput sequencing vs. others) and their corresponding disease area (related to a major disease area or unclassified) from 2008 to 2017
High-throughput sequencing | Other technology | ||||||
|---|---|---|---|---|---|---|---|
Year | Related to major disease area | Unclassified | Related to major disease area | Unclassified | OR | 95% CI | P value |
2008 | 15 | 6 | 720 | 428 | 1.49 | 0.57–3.86 | 0.499 |
2009 | 29 | 20 | 940 | 610 | 0.94 | 0.53–1.68 | 0.882 |
2010 | 81 | 71 | 1119 | 755 | 0.77 | 0.55–1.07 | 0.123 |
2011 | 149 | 116 | 1433 | 950 | 0.85 | 0.66–1.10 | 0.235 |
2012 | 211 | 202 | 1659 | 1016 | 0.64 | 0.52–0.79 | 2.99E-05 |
2013 | 280 | 313 | 1777 | 1144 | 0.58 | 0.48–0.69 | 1.39E-09 |
2014 | 466 | 497 | 1838 | 1201 | 0.61 | 0.53–0.71 | 5.32E-11 |
2015 | 644 | 571 | 1981 | 1355 | 0.77 | 0.68–0.88 | 1.27E-04 |
2016 | 1041 | 2079 | 1834 | 1193 | 0.33 | 0.29–0.36 | 1.31E-102 |
2017 | 1201 | 3425 | 1633 | 1636 | 0.35 | 0.32–0.39 | 6.76E-106 |
Total | 4117 (11.2%) | 7300 (19.9%) | 14934 (40.8%) | 10288 (28.1%) | 0.39 | 0.37–0.41 | 1.00E-322 |
